SMITHKLINE BEECHAM’s AUGMENTIN AUGMENTS 1991 REVENUES BY $942 MIL., OR 20% OF PHARMACEUTICAL SALES; SEROXAT HOLDS 11% SHARE OF U.K. ANTIDEPRESSANT MARKET

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".